Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends

A review of evolving trends in third line treatment of advanced gastric cancer shows sequential treatment approaches benefit a growing minority of patients and refining predictive biomarkers may further help patient selection.